Bartlett DW, Davis ME. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Research; 2006, 34(1): 322-333.
Bub JD, Miyazaki T, Iwamoto Y. Adiponectin as a growth inhibitor in prostate cancer cells. Biochemical and Biophysical Research Communications; 2006, 340(4): 1158-1166.
Campos JH, Hallam EA, Van NT, Kernstine KH. Devices for lung isolation used by anesthesiologists with limited thoracic experience - Comparison of double-lumen endotracheal tube, Univent (R) torque control blocker, and Arndt wire-guided endobronchial Blocker (R). Anesthesiology; 2006, 104(2): 261-266.
Chow WA, Victoria B, Gaytan P, Borden E, Goldblum J, Hicks D, Slovak ML. Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas. Cancer Genetics and Cytogenetics; 2006, 166(2): 95-100.
Chung V, Zhou B, Liu XY, Zhu L, Boo LM, Nguyen HV, Ann DK, Song J, Chen Y, Yen Y. SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone. Molecular Cancer Therapeutics; 2006, 5(3): 533-540.
Clark OH, Ajani J, Benson AB, Byrd D, Doherty GM, Engstrom PF, Ettinger DS, Gibbs JF, Heslin MJ, Kandeel F, Kessinger A, Kulke MH, Kvols L, Nemcek AA, Olson JA, Ratliff TW, Saltz L, Schteingart DE, Shah MH, Shibata S. Neuroendocrine tumors. J Natl Compr Canc Netw; 2006, 4(2): 102-38.
Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro CC, Jove R. Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clinical Cancer Research; 2006, 12(1): 11-19.
Han CH, Liu A, Schultheiss TE, Pezner RD, Chen YJ, Wong JY. Dosimetric comparisons of helical tomotherapy treatment plans and step-and-shoot intensity-modulated radiosurgery treatment plans in intracranl stereotactic radiosurgery. International Journal of Radiation Oncology Biology Physics; 2006, 65(2): 608-616.
Hu JC, Nelson RA, Wilson TG, Kawachi MH, Ramin SA, Lau C, Crocitto LE. Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy. Journal of Urology; 2006, 175(2): 541-546.
Juhasz A, Vassilakos A, Chew HK, Gandara D, Yen Y. Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment. Oncology Reports; 2006, 15(5): 1299-1304.
Kane SE. Cancer therapies targeted to the epidermal growth factor receptor and its family members. Expert Opinion on Therapeutic Patents; 2006, 16(2): 147-164.
Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J, Jove R. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Molecular Cancer Therapeutics; 2006, 5(3): 621-629.
La RC, Wang ZD, Lacey SF, Lalimarmo MM, Krishnan A, Longmate J, Diamond DJ. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara. Experimental Hematology; 2006, 34(4): 497-507.
Lara PN, Stadler WM, Longmate J, Quinn DI, Wexler J, Van LM, Twardowski P, Gumerlock PH, Vogelzang NJ, Vokes EE, Lenz HJ, Doroshow JH, Gandara DR. A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases. Clinical Cancer Research; 2006, 12(5): 1556-1563.
Leong SP, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL, Chu D, Biel M, Charney K, Wanebo H, Avisar E, Vetto J, Soong SJ. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Archives of Otolaryngology-Head & Neck Surgery; 2006, 132(4): 370-373.
McGonigle KF, Smith DD, Marx HF, Morgan RJ, Vasilevk SA, Roy S, Wong PT, Simpson JF, Wilczynski SP. Uterine effects of tamoxifen: a prospective study. International Journal of Gynecological Cancer; 2006, 16(2): 814-820.
Qiu WH, Zhou BS, Darwish D, Shao JM, Yen Y. Characterization of enzymatic properties of human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits. Biochemical and Biophysical Research Communications; 2006, 340(2): 428-434.
Sahebi F, Spielberger R, Kogut NM, Fung H, Falk PM, Parker P, Krishnan A, Rodriguez R, Nakamura R, Nademanee A, Popplewell L, Frankel P, Ruel C, Tin R, Ilieva P, Forman SJ, Somlo G. Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. Bone Marrow Transplantation; 2006, 37(9): 825-829.
Schluep T, Cheng JJ, Khin KT, Davis ME. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Cancer Chemotherapy and Pharmacology; 2006, 57(5): 654-662.
Schluep T, Hwang J, Cheng JJ, Heidel JD, Bartlett DW, Hollister B, Davis ME. Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models. Clinical Cancer Research; 2006, 12(5): 1606-1614.
Shao JM, Zhou BS, Di BA, Zhu LJ, Wang TL, Qi C, Shih J, Yen Y. A ferrous-Triapine complex mediates formation reactive oxygen species chat inactivate human ribonucleotide reductase. Molecular Cancer Therapeutics; 2006, 5(3): 586-592.
Wong JY, Liu A, Schultheiss T, Popplewell L, Stein A, Rosenthal J, Essensten M, Forman S, Somlo G. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: An alternative to standard total body irradiation. Biology of Blood and Marrow Transplantation; 2006, 12(3): 306-315.
Xue LJ, Zhou BS, Liu XY, Wang TL, Shih J, Qi C, Heung Y, Yen Y. Structurally dependent redox property of ribonucleotide reductase subunit p53R2. Cancer Research; 2006, 66(4): 1900-1905.
Zwerdling T, Krailo M, Monteleone P, Byrd R, Sato J, Dunaway R, Seibel N, Chen ZJ, Strain J, Reaman G. Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors - A report from the Children's Oncology Group. Cancer; 2006, 106(8): 1821-1828.
Beer TM, Tangen CM, Nichols CR, Margolin KA, Dreicer R, Stephenson WT, Quinn DI, Raghavan D, Crawford ED. Southwest oncology group phase II study of arsenic trioxide in patients with refractory germ cell malignancies. Cancer; 2006, 106(12): 2624-9.
Fong Y, Wagman L, Gonen M, Crawford J, Reed W, Swanson R, Pan C, Ritchey J, Stewart A, Choti M. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg; 2006, 243(6): 767-71; discussi
Kijima I, Phung S, Hur G, Kwok SL, Chen S. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res; 2006, 66(11): 5960-7.
Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD. Sunitinib in patients with metastatic renal cell carcinoma. Jama; 2006, 295(21): 2516-24.
Song L, Morris M, Bagui T, Lee FY, Jove R, Haura EB. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res; 2006, 66(11): 5542-8.
Wong JY, Chu DZ, Williams LE, Liu A, Zhan J, Yamauchi DM, Wilczynski S, Wu AM, Yazaki PJ, Shively JE, Leong L, Raubitschek AA. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. Cancer Biother Radiopharm; 2006, 21(2): 88-100.
Rini BI, Halabi S, Barrier R, Margolin KA, Avigan D, Logan T, Stadler WM, McCarthy PL, Linker CA, Small EJ. Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: A CALGB Intergroup Phase II Study. Biol Blood Marrow Transplant; 2006, 12(7): 778-85.
Wang Y, Lee KW, Chan FL, Chen S, Leung LK. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci; 2006, 92(1): 71-7.
Lara P, Koczywas M, Quinn D, Lenz H, Davies A, Lau D, Gumerlock P, Longmate J, Doroshow J, Schenkein D, Kashala O, Gandara D. Bortezomib plus docetaxel in advanced non-small cell lung cancer and other solid tumors: A phase I California cancer consortium trial. Journal of Thoracic Oncology; 2006, 1(2): 126-134.
Chow WA, Guo S, Valdes AF. Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1. Anticancer Drugs; 2006, 17(8): 891-903.
Lui K, Huang Y, Choi H, Yu S, Wong K, Chen S, Chan F. Molecular cloning and functional study of rat estrogen receptor-related receptor gamma in rat prostatic cells. Prostate; 2006; 66: 1600-1619.
Miale TD, Wong JY, Ahmed I, Wagman LD. Multimodal management, including precisely targeted irradiation, in a severe refractory case of Evans syndrome. Pediatr Blood Cancer; 2006, 47(5 Suppl): 726-8.
Morgan RJ, Alvarez RD, Armstrong DK, Chen LM, Copeland L, Fowler J, Gaffney DK, Gershenson D, Greer BE, Johnston C, Lancaster JM, Lele S, Matulonis U, Ozols RF, Remmenga SW, Sabbatini P, Soper J, Teng N. Ovarian cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw; 2006, 4(9): 912-39.
Pigazzi A, Ellenhorn JD, Ballantyne GH, Paz IB. Robotic-assisted laparoscopic low anterior resection with total mesorectal excision for rectal cancer. Surg Endosc; 2006, 20(10): 1521-5.
Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen ZJ, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ. Local control in pelvic Ewing sarcoma: Analysis from INT-0091 - A report from the Children's Oncology Group. Journal of Clinical Oncology; 2006, 24(24): 3838-3843.
Chen S, Masri S, Hong Y, Wang X, Phung S, Yuan Y, Wu X. New experimental models for aromatase inhibitor resistance. In Press. J. Steroid Biochem & Mol Biol; 2006.
Chen S, Masri S, Wang X, Phung S, Yuan Y, Wu X. What do we know about the mechanisms of aromatase inhibitor resistance? In press. J. Steroid Biochem. & Mol. Biol; 2006.
Chen S, Oh SR, Phung S, Hur G, Ye JJ, Kwok S, Shrode G, Belury M, Adams L, Williams D. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). In press. Cancer Research; 2006.
Hong Y, Chen S. Aromatase inhibitors: Structure features and biochemical characterization. In press. N.Y. Acad. Sci; 2006.
Hong Y, Yu B, Sherman M, Yuan Y, Zhou D, Chen S. Molecular basis for the aromatization reaction and irreversible inhibition of human aromatases by exemestance. In press. Mol. Endocrinol; 2006.
Liu X, Zhou B, Xue L, Shih J, Tye K, Lin W, Qi C, Chu PG, Un F, Wen W, Yen Y. Metatasis-Suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells. In Press. Clin Cancer Res; 2006.
Snyder DS, Palmer J, Stein A, Pullarkat V, Sahebi F, Cohen S, Vora N, Gaal K, Nakamura R, Forman SJ. Allogeneic Hematopoietic Cell Transplantation following reduced-intensity conditioning for treatment of myelofibrosis. Biology of Blood and Marrow Transplantation; 2006, 12(11): 1161-1168.
Wang X, Chen S. Aromatase destablizer: Novel action of exemestane, an FDA approved aromatase inhibitor. In press. Cancer Research; 2006.
Yang F, Huang X, YiT, Yen Y, Gonzales F, Moore D, Huang W. Spontaneous Development of Liver Tumors in The Absence of The Bile Acid Receptor FXR, CAN-06-1078. In Press. Cancer Research; 2006.
Zhou D, Ye JJ, Chen S. The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha. In press. Nucleic Acid Res; 2006.
Doroshow JH, McCoy S, Macdonald JS, Issell BF, Patel T, Cobb PW, Yost KJ, Abbruzzese JL. Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: A Southwest Oncology Group study. Investigational New Drugs; 2006, 24(6): 537-542.
Hesketh PJ, Chansky K, Lau DH, Doroshow JH, Moinpour CM, Chapman RA, Goodwin JW, Gross HM, Crowley JJ, Gandara DR. Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: A phase II trial of the Southwest Oncology Group (S0027). Journal of Thoracic Oncology; 2006, 1(6): 537-544.
Kaiser A, Schultheiss TE, Wong JY, Smith DD, Han C, Vora NL, Pezner RD, Chen YJ, Radany EH. Pitch, roll, and yaw variations in patient positioning. Int J Radiat Oncol Biol Phys; 2006, 66(3): 949-55.
Lee DH, Esworthy RS, Chu C, Pfeifer GP, Chu FF. Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases. Cancer Res; 2006, 66(20): 9845-51.
Lui K, Huang Y, Choi HL, Yu S, Wong KB, Chen S, Chan FL. Molecular cloning and functional study of rat estrogen receptor-related receptor gamma in rat prostatic cells. Prostate; 2006, 66(15): 1600-19.
Pantuck AJ, Thomas G, Belldegrun AS, Figlin RA. Mammalian target of rapamycin inhibitors in renal cell carcinoma: current status and future applications. Semin Oncol; 2006, 33(5): 607-13.
Shuch BM, Lam JS, Belldegrun AS, Figlin RA. Prognostic factors in renal cell carcinoma. Semin Oncol; 2006, 33(5): 563-75.
Un F, Oi C, Prosser M, Wang N, Zhou B, Bronner C, Yen Y. Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity. Anticancer Res; 2006, 26(4B): 2761-7.
Zhou B, Phan V, Liu X, Juhasz A, Chu PG, Yen Y. Production of a monoclonal antibody against the hRRM2 subunit of ribonucleotide reductase and immunohistochemistry study of human cancer tissues. Hybridoma (Larchmt); 2006, 25(5): 264-70.
Bhatia S, Krailo M, Chen Z, Burden L, Askin F, Dickman P, Grier H, Link M, Meyers P, Perlman E, Rausen A, Robison L, Vietti T, Miser J. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group. In Press. Blood First Edition Paper; 2006.
Ashing GK, Tejero J, Kim J, Padilla G. Predictive Models of HRQOL in a Population-based, Multiethnic Sample of Women with Breast Carcinoma. In Press. Quality of Life Research; 2006.
Kim J, Ashing GK, Kagawa SM, Tejero JS. Breast cancer among Asian Americans: is acculturation related to health-related quality of life?. Oncol Nurs Forum; 2006, 33(6): E90-9.
